Please use this identifier to cite or link to this item:
|Title:||Assessing the value of a new pharmaceutical|
|Authors:||O'Brien, Bernie J.|
Centre for Health Economics and Policy Analysis
|Keywords:||Cost-Benefit Analysis;Economics, Pharmaceutical;Feasibility Studies;Granulocyte Colony-Stimulating Factor;Managed Care Programs;Neoplasms;drug therapy;Patient Acceptance of Health Care;Relative Value Scales|
|Series/Report no.:||CHEPA working paper series no. 96-22|
|Description:||Bernie O'Brien ... [et al.].|
Includes bibliographical references (p. 25-28).
|Appears in Collections:||CHEPA Working Paper Series|
Files in This Item:
There are no files associated with this item.
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.